ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » California » Pain Medicine

Top Pain Medicine Prescribers in California

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
GEORGES ELKHOURY MD

Pain Medicine

7,134

$371K

852
459 are 65+

33%
patients receiving schedule two controlled substances

Avg: 43%

54%
patients receiving schedule three controlled substances

Avg: 38%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

7%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $102

CHARLES STEVENS M.D.

Pain Medicine

5,813

$554K

590
337 are 65+

56%
patients receiving schedule two controlled substances

Avg: 43%

43%
patients receiving schedule three controlled substances

Avg: 38%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

16%
prescriptions for brand name drugs

Avg: 22%

$95
Average prescription price

Avg: $102

NATHAN SINGER M.D.

Pain Medicine

5,052

$863K

189
73 are 65+

60%
patients receiving schedule two controlled substances

Avg: 43%

41%
patients receiving schedule three controlled substances

Avg: 38%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

18%
prescriptions for brand name drugs

Avg: 22%

$171
Average prescription price

Avg: $102

ROLAND REINHART M.D.

Pain Medicine

4,745

$636K

646
440 are 65+

57%
patients receiving schedule two controlled substances

Avg: 43%

25%
patients receiving schedule three controlled substances

Avg: 38%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

28%
prescriptions for brand name drugs

Avg: 22%

$134
Average prescription price

Avg: $102

RICHARD DOCHERTY MD

Pain Medicine

4,242

$707K

239
78 are 65+

58%
patients receiving schedule two controlled substances

Avg: 43%

54%
patients receiving schedule three controlled substances

Avg: 38%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 22%

$167
Average prescription price

Avg: $102

DHARMESH MEHTA MD

Pain Medicine

3,986

$280K

484
288 are 65+

47%
patients receiving schedule two controlled substances

Avg: 43%

43%
patients receiving schedule three controlled substances

Avg: 38%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

15%
prescriptions for brand name drugs

Avg: 22%

$70
Average prescription price

Avg: $102

FRANK LI M.D.

Pain Medicine

3,851

$301K

677
162 are 65+

80%
patients receiving schedule two controlled substances

Avg: 43%

27%
patients receiving schedule three controlled substances

Avg: 38%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 22%

$78
Average prescription price

Avg: $102

ANDREW HESSELTINE MD

Pain Medicine

3,563

$532K

446
206 are 65+

64%
patients receiving schedule two controlled substances

Avg: 43%

33%
patients receiving schedule three controlled substances

Avg: 38%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 22%

$149
Average prescription price

Avg: $102

BALDEV SINGH M.D.

Pain Medicine

3,361

$557K

197
58 are 65+

60%
patients receiving schedule two controlled substances

Avg: 43%

60%
patients receiving schedule three controlled substances

Avg: 38%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 22%

$166
Average prescription price

Avg: $102

RODGER ORMAN M.D.

Pain Medicine

3,145

$507K

177
73 are 65+

61%
patients receiving schedule two controlled substances

Avg: 43%

49%
patients receiving schedule three controlled substances

Avg: 38%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 22%

$161
Average prescription price

Avg: $102

OSEMWOTA OMOIGUI MD

Pain Medicine

3,082

$335K

81
15 are 65+

86%
patients receiving schedule two controlled substances

Avg: 43%

35%
patients receiving schedule three controlled substances

Avg: 38%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 22%

$109
Average prescription price

Avg: $102

CHITTA THIAGARAJAH M.D.

Pain Medicine

2,769

$107K

377
129 are 65+

42%
patients receiving schedule two controlled substances

Avg: 43%

59%
patients receiving schedule three controlled substances

Avg: 38%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

6%
prescriptions for brand name drugs

Avg: 22%

$39
Average prescription price

Avg: $102

DON PAXTON MD

Pain Medicine

2,748

$239K

434
283 are 65+

55%
patients receiving schedule two controlled substances

Avg: 43%

56%
patients receiving schedule three controlled substances

Avg: 38%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

17%
prescriptions for brand name drugs

Avg: 22%

$87
Average prescription price

Avg: $102

KIUMARS ARFAI MD

Pain Medicine

2,743

$248K

291
177 are 65+

51%
patients receiving schedule two controlled substances

Avg: 43%

44%
patients receiving schedule three controlled substances

Avg: 38%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 22%

$90
Average prescription price

Avg: $102

VAN VU M.D.

Pain Medicine

2,693

$151K

281
128 are 65+

51%
patients receiving schedule two controlled substances

Avg: 43%

52%
patients receiving schedule three controlled substances

Avg: 38%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $102

ROBERT SALAZAR MD

Pain Medicine

2,643

$198K

366
156 are 65+

52%
patients receiving schedule two controlled substances

Avg: 43%

44%
patients receiving schedule three controlled substances

Avg: 38%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 22%

$75
Average prescription price

Avg: $102

JOE PARK M.D.

Pain Medicine

2,545

$189K

264
114 are 65+

46%
patients receiving schedule two controlled substances

Avg: 43%

41%
patients receiving schedule three controlled substances

Avg: 38%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

15%
prescriptions for brand name drugs

Avg: 22%

$74
Average prescription price

Avg: $102

CRAIG ROSENBLUM M.D.

Pain Medicine

2,501

$272K

183
110 are 65+

56%
patients receiving schedule two controlled substances

Avg: 43%

25%
patients receiving schedule three controlled substances

Avg: 38%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 22%

$109
Average prescription price

Avg: $102

MICHAEL YANG MD

Pain Medicine

2,459

$202K

275
116 are 65+

48%
patients receiving schedule two controlled substances

Avg: 43%

36%
patients receiving schedule three controlled substances

Avg: 38%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 22%

$82
Average prescription price

Avg: $102

BRIAN GWARTZ M.D.

Pain Medicine

2,353

$305K

150
67 are 65+

58%
patients receiving schedule two controlled substances

Avg: 43%

52%
patients receiving schedule three controlled substances

Avg: 38%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 22%

$130
Average prescription price

Avg: $102

CARL HESS MD

Pain Medicine

2,340

$424K

127
59 are 65+

64%
patients receiving schedule two controlled substances

Avg: 43%

46%
patients receiving schedule three controlled substances

Avg: 38%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 22%

$181
Average prescription price

Avg: $102

AFSHIN GERAYLI M.D.

Pain Medicine

2,208

$166K

397
304 are 65+

46%
patients receiving schedule two controlled substances

Avg: 43%

38%
patients receiving schedule three controlled substances

Avg: 38%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

17%
prescriptions for brand name drugs

Avg: 22%

$75
Average prescription price

Avg: $102

ALICJA STEINER M.D.

Pain Medicine

2,119

$122K

152
38 are 65+

78%
patients receiving schedule two controlled substances

Avg: 43%

20%
patients receiving schedule three controlled substances

Avg: 38%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

12%
prescriptions for brand name drugs

Avg: 22%

$57
Average prescription price

Avg: $102

ATHANASIOS MAGIMBI MD

Pain Medicine

2,091

$169K

179
110 are 65+

78%
patients receiving schedule two controlled substances

Avg: 43%

27%
patients receiving schedule three controlled substances

Avg: 38%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

35%
prescriptions for brand name drugs

Avg: 22%

$81
Average prescription price

Avg: $102

NORMAN PANG MD

Pain Medicine

2,072

$301K

131
50 are 65+

68%
patients receiving schedule two controlled substances

Avg: 43%

57%
patients receiving schedule three controlled substances

Avg: 38%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

26%
prescriptions for brand name drugs

Avg: 22%

$145
Average prescription price

Avg: $102

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank